OM insider trading
NasdaqGS HealthcareOutset Medical, Inc.: insider trade history from SEC Form 4 filings.
About Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Company website: www.outsetmedical.com
OM insider activity at a glance
FilingIQ tracks 633 insider transactions for OM in filings since Sep 17, 2020. The most recent transaction is dated Oct 2, 2026.
Across the full history, 9 open-market purchases
and 343 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on OM insider trades is 53.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest OM Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for OM?
- FilingIQ tracks 633 Form 4 insider transactions for OM (Outset Medical, Inc.), covering filings from Sep 17, 2020 onwards. 5 of those are dated within the last 90 days.
- Are OM insiders net buyers or net sellers?
- Across the full Form 4 history for OM, 9 transactions (1%) were open-market purchases and 343 (54%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does OM insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is OM in?
- Outset Medical, Inc. (OM) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $64.64M.
Methodology & sources
Every OM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.